After 4 weeks of PTH treatment (before injection of myeloma cells), BMD of the implanted nonmyelomatous rabbit bones was 60±16% higher than levels before PTH treatment (p<0.0001) (Figure 4B). The gene discussed is PTH; the disease is plasma cell myeloma.